John Lewis covid-19 vaccine John Lewis

Phase 1 clinical trial for Alberta-made COVID-19 vaccine candidate ‘imminent’

Reading now: 121
globalnews.ca

Edmonton-based Entos Pharmaceuticals, led by University of Alberta researcher Dr. John Lewis, has a COVID-19 vaccine candidate ready to head into Phase 1 of a clinical trial.

Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA